This special discussion includes representatives from the Health Law Section, Commission on Lawyer Assistance Programs, Diversity, Equity, and Inclusion Advisory Council, Law Student Division, Senior Lawyers Division, and Young Lawyers Division. The roundtable discussion has panelists reflecting on all of their professional (some personal) transitions and the emotional levels they encountered through each transition.

Lisbeth Bulmash from JAMS joins Voices in Health Law to provide a grounding in what alternative dispute resolution covers. After discussing the basics of what ADR means, Lisbeth discusses issues that commonly bring healthcare parties to pursue ADR. Lisbeth also discusses how AI is currently helping the ADR process along with some cautionary notes.

In the final installment of a three-part series with VMG Health, host Jeff Wurzburg is joined by Elizabeth Burrows, Managing Director in VMG's Health Revenue Management Practice, to discuss the 340B drug pricing program — a critical but often underutilized revenue source for covered entities. Elizabeth covers how qualifying organizations can maximize 340B revenue, the strategic case for in-house pharmacies, compliance essentials including audit preparedness and database accuracy, and key trends to watch in 2026 — including the potential rebate model shift, manufacturer restrictions, and the implications of TrumpRx on 340B pricing.

In part two of a three-part series with VMG Health, host Jeff Wurzburg is joined by coding and revenue cycle expert Debra Rossi to break down key regulatory guidelines from the 2026 Medicare Physician Fee Schedule. Debra covers Incident-To billing requirements, CMS Split/Shared Visit rules, critical care billing under codes 99291 and 99292, and E&M updates

In this first installment of a three-part series sponsored by VMG Health, host Jeff Wurzburg is joined by Pam D'Apuzzo, Managing Director of Coding, Audit, and Compliance at VMG Health, for a timely breakdown of the 2026 Medicare Physician Fee Schedule final rule.

Pam covers the February 2026 extension of Medicare telehealth flexibilities through 2027, including audio-only and audio-video service rules, state licensure considerations, and documentation requirements. She also walks through the 2.5% conversion factor increase, practice expense methodology changes, work RVU adjustments for surgical procedures, and updates to the Medicare telehealth approved services list. The episode closes with new RPM and RTM billing thresholds that expand reimbursement opportunities for more providers.

In this episode of Voices in Health Law, host Ramana Rameswaran sits down with Greg Fliszar from Baker Donelson to discuss the federal 340B program and the impacts of current changes. This episode is a preview of what Greg will be discussing in his presentation at the 2026 Emerging Issues in Healthcare Law Conference titled “The 340B Drug Pricing Program - A Target for Transformation.” To register for EMI or to find out more about sessions and activities, go to ambar.org/EMI2026.

Ashley Osak from Polsinelli joins Voices in Health Law to break down what it means for a healthcare organization to pursue a transaction with private equity. Ashley discusses the types of transactions that private equity will pursue along with increasing oversight and review by state agencies. Ashley also predicts what the near term future may hold for private equity in healthcare.

In this episode of Voices in Health Law, Andy Demetriou sits down with Arthur Peabody, Chair of the ABA Health Law Section Task Force on Ethics and Professional Responsibility and Tracey Frisch of the American Arbitration Association to discuss the recently released American Bar Association Formal Opinion 518, which addresses the duties and responsibilities of lawyers who act as mediators.

Host Andy Demetriou talks with Tricia Asaro of Greenberg Traurig about the history and evolution of managed care, the key players in the industry, current affordability and access challenges and her perspectives on the future of managed care.

In this episode, Stephen Holland, Senior Counsel at Brownstein Hyatt Farber Schreck, LLP is interviewed by members of the Washington Health Law Summitt planning committee (Sam Ruddy, Crowell & Moring, LLP and Tenia Clayton, Baker Donelson). Stephen, who will be speaking at the Washington Health Summit occurring on December 8-9 in Washington, DC, gives his candid insights about the government shutdown and Congressional pathways to reopening the government, as well as its potential impacts on health policy going forward. If you are navigating the current intersection of law and health policy, this episode delivers timely insights you won't want to miss and hopefully sparks your interest in attending the Washington Health Law Summit next month! For more information and to register go to ambar.org/whs2025